Seattle, WANCT06722755Now EnrollingIRB Ready

Stroke Patients Clinical Trial in Seattle, WA

Access cutting-edge stroke patients treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.

Sponsored by University of Washington

Quick Self-Assessment

See if you qualify for this Seattle location

Preparing your pre-screening questions…

Expert Care in Seattle

Access stroke patients specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related stroke patients treatment provided free

Apply for This Seattle Location

Check if you qualify for this stroke patients clinical trial in Seattle, WA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Seattle

    Convenient for WA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Seattle site if eligible
  4. 4Begin participation

About This Stroke Patients Study in Seattle

The SCOUTS 3 study aims to test the effectiveness of an intensive CPAP (Continuous Positive Airway Pressure) therapy support program compared to usual care in stroke patients with obstructive sleep apnea (OSA) during inpatient rehabilitation (IPR). The study is a multicenter randomized controlled trial (RCT) involving recruitment of about 250 participants across two institutions and randomization of about 200 participants. It compares an intensive support (IS) program for CPAP use with standard support (SS) to evaluate the effectiveness of the IS intervention in increasing CPAP usage during and after stroke rehabilitation. The Intensive Support (IS) group will receive a multicomponent intensive behavioral adherence program, which includes a CPAP technical support intervention, Motivational Enhancement Therapy (MET), and a Mobile Health intervention. Outcomes measured include CPAP adherence as measured by average nightly use in minutes between randomization and 3 months and the modified Rankin Scale (mRS-9Q) to evaluate stroke recovery.

Sponsor: University of Washington

Who Can Participate

Inclusion Criteria

Age 18 years or older
Head CT or brain MRI demonstrating an acute ischemic infarction or intraparenchymal hemorrhage within past 30 days
Person providing consent (patient or legally authorized representative (LAR)) able to be consented in English or Spanish.

Exclusion Criteria

Unable to obtain informed consent from participant or LAR in English or Spanish
Incarcerated
Known pregnancy-determined by reviewing clinical data
Current mechanical ventilation, tracheostomy, or supplemental oxygen use \> 4L/min
Use of positive airway pressure within 14 days prior to stroke
History of pneumothorax, bullous emphysema or other serious co-morbid conditions which limit CPAP use
Stroke related to tumors, vascular malformations or subarachnoid hemorrhage
Active use of sedative drugs that can interfere with testing for obstructive sleep apnea (OSA) including any benzodiazepine, barbiturate, general anesthesia, or conscious sedation within the prior 48 hours of the planned portable sleep apnea study
Anticipated inpatient rehabilitation length of stay \< 5 nights
Co-morbid conditions that limit OSA testing or CPAP use in the judgement of the study team
Recent cranial or spinal surgery with known or possible CSF leak or pneumocephalus within past 3 months
Patients at significant risk of aspiration that could render the patient at risk of harm from use of CPAP, in the opinion of the site PI.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Seattle?

Yes, this clinical trial (NCT06722755) has an active research site in Seattle, WA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Stroke Patients Treatment Options in Seattle, WA

If you're searching for stroke patients treatment options in Seattle, WA, this clinical trial (NCT06722755) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stroke patients specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all stroke patients clinical trials near you to find additional studies recruiting in your area.

More Stroke Trials in Seattle, WA

See all stroke clinical trials recruiting in Seattle — not just this study.

Browse Stroke Trials in Seattle →

Browse More Trials by Condition

Ready to Join in Seattle?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Seattle, WA